Ultragenyx Pharmaceutical (RARE) stock is in focus as the company completes FDA rolling submission for FDA approval of its ...

According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

Betting everything on a single growth stock carries massive danger, but in this thought experiment, ChatGPT endorsed a FTSE ...

This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...

The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...

Understanding how cells decide their fate is a central challenge in biology, complicated by the fact that single-cell RNA ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Researchers have reported a novel colour-coded genetic approach that has enabled male and female mosquitoes to be separated ...

Patients submitted for consideration for treatment with GS010/Lumevoq must meet specific eligibility criteria, including the length of time since the onset of their vision loss.

Today Leo spent some time with Lian Li at their booth looking at all the new hardware goodies they are releasing - including, ...

The platform is described in a peer-reviewed publication in JACC: Basic to Translational Science under the title: “Next-Generation Percutaneous Catheter–Based Closed-Loop Perfusion Concept Enables ...